Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BioNTech
Biotech
BioNTech, BMS tout first global data for PD-L1xVEGF drug in SCLC
BioNTech and BMS have picked the pumitamig dose for the Rosetta Lung-01 phase 3 trial in first-line extensive-stage small cell lung cancer.
Angus Liu
Sep 8, 2025 11:00am
BioNTech's ADC beats Roche’s Kadcyla in breast cancer phase 3
Sep 5, 2025 7:30am
BioNTech cuts 90 more US jobs as part of pipeline realignment
Aug 5, 2025 1:24pm
Sarepta shakes up C-suite amid org overhaul—Chutes & Ladders
Jul 18, 2025 8:30am
BioNTech's chief strategy officer heads for the exit
Jul 17, 2025 10:55am
Fierce Pharma
BioNTech to wind down cell therapy manufacturing in Maryland
Jun 18, 2025 10:23am